References
- World Health Organization. Hypertension. Geneva: World Health Organization; 2023.
https://www.who.int/news-room/fact-sheets/detail/hypertension . Accessed 22 Mar 2024. - Aekplakorn W, Chariyalertsak S, Kessomboon P, Assanangkornchai S, Taneepanichskul S, Goldstein A, et al. Trends in hypertension prevalence, awareness, treatment, and control in the Thai population, 2004 to 2020. BMC Public Health. 2024;24:3149. DOI: 10.1186/s12889-024-20643-1
- Forouzanfar MH, Liu P, Roth GA, Ng M, Biryukov S, Marczak L, et al. Global burden of hypertension and systolic blood pressure of at least 110 to 115 mm Hg, 1990–2015. JAMA. 2017;317(2):165–182. Erratum in JAMA. 2017;317(6):648. DOI: 10.1001/jama.2016.19043
- Forouzanfar MH, Afshin A, Alexander LT, Anderson HR, Bhutta ZA, Biryukov S, et al. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: A systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388:1659–1724. DOI: 10.1016/S0140-6736(16)31679-8
- Unger T, Borghi C, Charchar F, Khan NA, Poulter NR, Prabhakaran D, et al. 2020 International Society of Hypertension Global Hypertension Practice Guidelines. Hypertension. 2020;75(6):1334–1357. DOI: 10.1161/HYPERTENSIONAHA.120.15026
- GBD 2017 Causes of Death Collaborators. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392:1736–1788. doi: 10.1016/S0140-6736(18)32203-7.
- Dai H, Much AA, Maor E, Asher E, Younis A, Xu Y, et al. Global, regional, and national burden of ischaemic heart disease and its attributable risk factors, 1990–2017: Results from the Global Burden of Disease Study 2017. Eur Heart J Qual Care Clin Outcomes. 2022;8(1):50–60. DOI: 10.1093/ehjqcco/qcaa076
- Sakboonyarat B, Rangsin R. Hospital admission and mortality rates for ischemic heart disease in Thailand: 2012–2021. BMC Res Notes. 2024;17:142. DOI: 10.1186/s13104-024-06803-x
- World Health Organization. The Kingdom of Thailand health system review. Geneva: World Health Organization; 2015.
- The National Health Security Office (TH). DAMUS: data archival for maximum utilization system. 2022.
https://dmht.thaimedresnet.org . Accessed 7 Oct 2022. - Sakboonyarat B, Rangsin R. Characteristics and clinical outcomes of people with hypertension receiving continuous care in Thailand: A cross-sectional study. Lancet Reg Health Southeast Asia. 2024;21:100319. DOI: 10.1016/j.lansea.2023.100319
- Safiri S, Karamzad N, Singh K, Carson-Chahhoud K, Adams C, Nejadghaderi SA, et al. Burden of ischemic heart disease and its attributable risk factors in 204 countries and territories, 1990–2019. Eur J Prev Cardiol. 2022;29:420–431. DOI: 10.1093/eurjpc/zwab213
- The Healthcare Accreditation Institute. Hospital and healthcare standards. 4th ed. Nonthaburi: The Healthcare Accreditation Institute (Public Organization); 2019.
- Tangcharoensathien V, Limwattananon S, Patcharanarumol W, Thammatacharee J, Jongudomsuk P, Sirilak S. Achieving universal health coverage goals in Thailand: The vital role of strategic purchasing. Health Policy Plan. 2015;30:1152–1161. DOI: 10.1093/heapol/czu120
- WHO. ICD-10: International statistical classification of diseases and related health problems: Tenth revision. Geneva: World Health Organization; 2016.
- Inoue S. The Asia-Pacific perspective: Redefining obesity and its treatment. Melbourne: Health Communications Australia Pty Ltd; 2000.
- Zou G. A modified Poisson regression approach to prospective studies with binary data. Am J Epidemiol. 2004;159:702–706. DOI: 10.1093/aje/kwh090
- Linden A, Mathur MB, VanderWeele TJ. Conducting sensitivity analysis for unmeasured confounding in observational studies using E-values: The evalue package. Stata J. 2020;20(1):162–175. DOI: 10.1177/1536867X20909696
- Wang F, Yu Y, Mubarik S, Zhang Y, Liu X, Cheng Y, et al. Global burden of ischemic heart disease and attributable risk factors, 1990–2017: A secondary analysis based on the global burden of disease study 2017. Clin Epidemiol. 2021;13:859–870. DOI: 10.2147/CLEP.S317787
- World Health Organization. Hypertension care in Thailand: Best practices and challenges, 2019. Bangkok: World Health Organization. Country Office for Thailand; 2019.
- Thai Hypertension Society. Thai guideline on the treatment of hypertension: 2012 update 2015. Bangkok: Thai Hypertension Society; 2015.
- Kunanon S, Chattranukulchai P, Chotruangnapa C, Kositanurit W, Methavigul K, Boonyasirinant T, et al. 2019 Thai guidelines on the treatment of hypertension: Executive summary. J Med Assoc Thai. 2021;104:1729–1738. DOI: 10.35755/jmedassocthai.2021.10.12199
- NCD Countdown 2030 Collaborators. NCD Countdown 2030: Pathways to achieving Sustainable Development Goal target 3.4. Lancet. 2020;396:918–934. DOI: 10.1016/S0140-6736(20)31761-X
- Strategy and Planing Division, Ministry of Public Health (TM). Strategy, key performance index, and guideline for data collection, The Ministry of Public Health, Thailand (Fiscal year 2015). Nonthaburi: Ministry of Public Health; 2015.
- Aekplakorn W. Thai National Health Examination Survey VI (2019–2020); 2019.
https://online.fliphtml5.com/bcbgj/znee/#p=187 . Accessed 3 Oct 2023. - Wenger NK. Clinical characteristics of coronary heart disease in women: Emphasis on gender differences. Cardiovasc Res. 2002;53(3):558–567. DOI: 10.1016/S0008-6363(01)00511-9
- Tatsanavivat P, Klungboonkrong V, Chirawatkul A, Bhuripanyo K, Manmontri A, Chitanondh H, et al. Prevalence of coronary heart disease and major cardiovascular risk factors in Thailand. Int J Epidemiol. 1998;27(3):405–409. DOI: 10.1093/ije/27.3.405
- Lavie CJ, Ozemek C, Carbone S, Katzmarzyk PT, Blair SN. Sedentary behavior, exercise, and cardiovascular health. Circ Res. 2019;124(5):799–815. DOI: 10.1161/CIRCRESAHA.118.312669
- Bechthold A, Boeing H, Schwedhelm C, Hoffmann G, Knüppel S, Iqbal K, et al. Food groups and risk of coronary heart disease, stroke and heart failure: A systematic review and dose-response meta-analysis of prospective studies. Crit Rev Food Sci Nutr. 2019;59(7):1071–1090. DOI: 10.1080/10408398.2017.1392288
- Gladdish S, Rajkumar C. Prevention of cardiac disease in the elderly. J Cardiovasc Risk. 2001;8(5):271–277. DOI: 10.1177/174182670100800505
- Grady D, Rubin SM, Petitti DB, Fox CS, Black D, Ettinger B, et al. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med. 1992;117:1016–1037. DOI: 10.7326/0003-4819-117-12-1016
- Shahar E, Folsom AR, Salomaa VV, Stinson VL, McGovern PG, Shimakawa T, et al. Relation of hormone-replacement therapy to measures of plasma fibrinolytic activity. Atherosclerosis Risk in Communities (ARIC) Study Investigators. Circulation. 1996;93(11):1970–1975. DOI: 10.1161/01.cir.93.11.1970
- Gheisari F, Emami M, Raeisi Shahraki H, Samipour S, Nematollahi P. The role of gender in the importance of risk factors for coronary artery disease. Cardiol Res Pract. 2020;6527820:6. DOI: 10.1155/2020/6527820
- Department of Medical Services, Ministry of Public Health in Thailand. Handbook on self-management education and support for priests with diabetes and hypertension. Vol. 1. Nonthaburi: Ministry of Public Health; 2023.
- Sakboonyarat B, Rangsin R. Prevalence and associated factors of ischemic heart disease (IHD) among patients with diabetes mellitus: A nation-wide, cross-sectional survey. BMC Cardiovasc Disord. 2018;18:151. DOI: 10.1186/s12872-018-0887-0
- Ma H, Wang X, Li X, Heianza Y, Qi L. Adding salt to foods and risk of cardiovascular disease. J Am Coll Cardiol. 2022;80(23):2157–2167. DOI: 10.1016/j.jacc.2022.09.039
- Chailimpamontree W, Kantachuvesiri S, Aekplakorn W, Lappichetpaiboon R, Sripaiboonkij Thokanit N, Vathesatogkit P, et al. Estimated dietary sodium intake in Thailand: A nationwide population survey with 24-hour urine collections. J Clin Hypertens. 2021;23(4):744–754. DOI: 10.1111/jch.14147
- Sakboonyarat B, Pima W, Chokbumrungsuk C, Pimpak T, Khunsri S, Ukritchon S, et al. National trends in the prevalence of glycemic control among patients with type 2 diabetes receiving continuous care in Thailand from 2011 to 2018. Sci Rep. 2021;11:14260. DOI: 10.1038/s41598-021-93733-4
- Kobwanthanakun S. Drug expenditure for medical healthcare system in BMA Medical College and Vajira Hospital. Vajira Med J J Urban Med. 2010;54:67–78.
https://he02.tci-thaijo.org/index.php/VMED/article/view/435 - Kubota Y, Heiss G, Maclehose RF, Roetker NS, Folsom AR. Association of educational attainment with lifetime risk of cardiovascular disease the atherosclerosis risk in communities study. JAMA Intern Med. 2017;177(8):1165–1172. DOI: 10.1001/jamainternmed.2017.1877
- Magnani JW, Ning H, Wilkins JT, Lloyd-Jones DM, Allen NB. Educational attainment and lifetime risk of cardiovascular disease. JAMA Cardiol. 2024;9(1):45–54. DOI: 10.1001/jamacardio.2023.3990
- Sakboonyarat B, Rangsin R, Kantiwong A, Mungthin M. Prevalence and associated factors of uncontrolled hypertension among hypertensive patients: A nation-wide survey in Thailand. BMC Res Notes. 2019;12:380. DOI: 10.1186/s13104-019-4417-7
- Dal Canto E, Ceriello A, Rydén L, Ferrini M, Hansen TB, Schnell O, et al. Diabetes as a cardiovascular risk factor: An overview of global trends of macro and micro vascular complications. Eur J Prev Cardiol. 2019;26(2 suppl.):25–32. DOI: 10.1177/2047487319878371
- Jankowski J, Floege J, Fliser D, Böhm M, Marx N. Cardiovascular disease in chronic kidney disease pathophysiological insights and therapeutic options. Circulation. 2021;143(11):1157–1172. DOI: 10.1161/CIRCULATIONAHA.120.050686
- Shahandeh N, Chowdhary H, Middlekauff HR. Vaping and cardiac disease. Heart. 2021;107:1530–1535. DOI: 10.1136/heartjnl-2020-318150
- Poirier P, Giles TD, Bray GA, Hong Y, Stern JS, Pi-Sunyer FX, et al. Obesity and cardiovascular disease: Pathophysiology, evaluation, and effect of weight loss. Arterioscler Thromb Vasc Biol. 2006;26(5):968–976. DOI: 10.1161/01.ATV.0000216787.85457.f3
- Powell-Wiley TM, Poirier P, Burke LE, Després JP, Gordon-Larsen P, Lavie CJ, et al. Obesity and cardiovascular disease: A scientific statement from the American Heart Association. Circulation. 2021;143(21):e984–e1010. DOI: 10.1161/CIR.0000000000000973
- Qin W, Yang J, Deng C, Ruan Q, Duan K. Efficacy and safety of semaglutide 2.4 mg for weight loss in overweight or obese adults without diabetes: An updated systematic review and meta-analysis including the 2-year STEP 5 trial. Diabetes Obes Metab. 2024;26(3):911–923. DOI: 10.1111/dom.15386
- Carey RM, Muntner P, Bosworth HB, Whelton PK. Prevention and control of hypertension: JACC health promotion series. J Am Coll Cardiol. 2018;72:1278–1293. DOI: 10.1016/j.jacc.2018.07.008
- Angeli F, Reboldi G, Verdecchia P. Hypertension and the J-curve phenomenon: Implications for tight blood pressure control. Hypertension Res. 2013;36:109–111 DOI: 10.1038/hr.2012.165
- Alexeeff SE, Liao NS, Liu X, Van Den Eeden SK, Sidney S. Long-term PM2.5 exposure and risks of ischemic heart disease and stroke events: Review and meta-analysis. J Am Heart Assoc. 2021;10(1). DOI: 10.1161/JAHA.120.016890
- Alahmad B, Khraishah H, Royé D, Vicedo-Cabrera AM, Guo Y, Papatheodorou SI, et al. Associations between extreme temperatures and cardiovascular cause-specific mortality: Results from 27 countries. Circulation. 2023;147(1):35–46. DOI: 10.1161/CIRCULATIONAHA.122.061832